Meyka Pro banner
Blend Labs, Inc.

Blend Labs, Inc. Fundamental Analysis (NYSE: BLND)

BLNDNYSE
TechnologySoftware - Application
$1.72
$0.03(1.78%)
U.S. Market is Open · 11:04

Blend Labs, Inc. Fundamental Analysis (NYSE: BLND)

Blend Labs, Inc. (NYSE: BLND) shows weak financial fundamentals with a PE ratio of -18.19, profit margin of -4.40%, and ROE of -12.24%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position14.07%
PEG Ratio-0.23
Current Ratio1.78

Areas of Concern

ROE-12.24%
Operating Margin-14.42%
We analyze BLND's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 53.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
53.6/100

We analyze BLND's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLND struggles to generate sufficient returns from assets.

ROA > 10%
-3.49%

Valuation Score

Excellent

BLND trades at attractive valuation levels.

PE < 25
-18.19
PEG Ratio < 2
-0.23

Growth Score

Weak

BLND faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

BLND maintains a strong and stable balance sheet.

Debt/Equity < 1
-2.96
Current Ratio > 1
1.78

Profitability Score

Weak

BLND struggles to sustain strong margins.

ROE > 15%
-1224.37%
Net Margin ≥ 15%
-4.40%
Positive Free Cash Flow
No

Key Financial Metrics

Is BLND Expensive or Cheap?

P/E Ratio

BLND trades at -18.19 times earnings. This suggests potential undervaluation.

-18.19

PEG Ratio

When adjusting for growth, BLND's PEG of -0.23 indicates potential undervaluation.

-0.23

Price to Book

The market values Blend Labs, Inc. at -7.87 times its book value. This may indicate undervaluation.

-7.87

EV/EBITDA

Enterprise value stands at 65.90 times EBITDA. This signals the market has high growth expectations.

65.90

How Well Does BLND Make Money?

Net Profit Margin

For every $100 in sales, Blend Labs, Inc. keeps $-4.40 as profit after all expenses.

-4.40%

Operating Margin

Core operations generate -14.42 in profit for every $100 in revenue, before interest and taxes.

-14.42%

ROE

Management delivers $-12.24 in profit for every $100 of shareholder equity.

-12.24%

ROA

Blend Labs, Inc. generates $-3.49 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.49%

Following the Money - Real Cash Generation

Operating Cash Flow

Blend Labs, Inc. generates limited operating cash flow of $-1.45M, signaling weaker underlying cash strength.

$-1.45M

Free Cash Flow

Blend Labs, Inc. generates weak or negative free cash flow of $-9.14M, restricting financial flexibility.

$-9.14M

FCF Per Share

Each share generates $-0.04 in free cash annually.

$-0.04

FCF Yield

BLND converts -2.33% of its market value into free cash.

-2.33%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-18.19

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.23

vs 25 benchmark

P/B Ratio

Price to book value ratio

-7.87

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.26

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-2.96

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.78

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.12

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.17

vs 25 benchmark

How BLND Stacks Against Its Sector Peers

MetricBLND ValueSector AveragePerformance
P/E Ratio-18.1935.40 Better (Cheaper)
ROE-12.24%692.00% Weak
Net Margin-4.40%-137240.00% (disorted) Weak
Debt/Equity-2.960.45 Strong (Low Leverage)
Current Ratio1.783.41 Neutral
ROA-3.49%256.00% Weak

BLND outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Blend Labs, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Growth, Innovation, High Beta

EPS CAGR

N/A

Industry Style: Growth, Innovation, High Beta

FCF CAGR

N/A

Industry Style: Growth, Innovation, High Beta

Fundamental Analysis FAQ